Brown Advisory Securities, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brown Advisory Securities, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$370,000
-6.1%
10,000
-23.1%
0.22%
+28.6%
Q4 2021$394,000
-24.4%
13,000
-16.1%
0.17%
+9.1%
Q3 2021$521,000
-3.3%
15,500
+14.8%
0.15%
+83.3%
Q2 2021$539,000
+119.1%
13,500
+146.6%
0.08%
+100.0%
Q1 2021$246,000
-16.0%
5,475
+5.8%
0.04%
-16.0%
Q4 2020$293,000
+14.0%
5,175
-4.6%
0.05%
-3.8%
Q3 2020$257,000
-12.9%
5,425
+13.0%
0.05%
-17.5%
Q2 2020$295,000
+19.4%
4,8000.0%0.06%0.0%
Q1 2020$247,000
-14.2%
4,8000.0%0.06%
-8.7%
Q4 2019$288,0000.0%4,8000.0%0.07%
-14.8%
Q3 2019$288,000
-6.5%
4,8000.0%0.08%
-1.2%
Q2 2019$308,000
-25.1%
4,800
-5.9%
0.08%
-15.5%
Q1 2019$411,000
+24.5%
5,100
-17.1%
0.10%
+54.0%
Q4 2018$330,000
+9.3%
6,151
+4.7%
0.06%
+28.6%
Q3 2018$302,000
+29.6%
5,875
+5.4%
0.05%
+22.5%
Q2 2018$233,000
-6.4%
5,575
-1.8%
0.04%
-13.0%
Q1 2018$249,000
-12.6%
5,6750.0%0.05%
-16.4%
Q4 2017$285,000
-13.9%
5,675
-13.7%
0.06%
-23.6%
Q3 2017$331,000
-1.2%
6,5750.0%0.07%
-6.5%
Q2 2017$335,000
+23.2%
6,575
-3.2%
0.08%
+14.9%
Q1 2017$272,000
-16.0%
6,7900.0%0.07%
-23.9%
Q4 2016$324,000
+19.6%
6,790
-8.1%
0.09%
+11.4%
Q3 2016$271,0007,3900.08%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders